Cumberland Pharmaceuticals Inc.;Vanderbilt University
发明人:
Leo PAVLIV,James WEST,Ines Macias-Perez,Erica Carrier
申请号：
US16050798
公开号：
US20180353481A1
申请日:
2018.07.31
申请国别(地区):
US
年份:
2018
代理人:
摘要：
The present invention is directed to methods of treating and/or ameliorating muscular dystrophy and/or treating cardiomyopathy in muscular dystrophy patients by administration of a therapeutically effective amount of a thromboxane A2 receptor antagonist.
